Background Cardiovascular disease (CVD) is an important cause of morbidity and mortality
in peritoneal dialysis (PD) patients. Cardiovascular calcification (CVC) is highly prevalent in …

Background/Aims: Cardiovascular disease (CVD) is an important cause of morbidity and
mortality in hemodialysis patients. Vascular calcification is thought to play an important role …

Purpose Considering its prognostic usefulness and the relationship with chronic kidney
disease, we analyzed the clinical utility of soluble urokinase plasminogen activator receptor …

Chronic kidney disease (CKD) will progress to end stage without treatment, the decline off
renal function may not linear. A sensitive marker such as soluble urokinase-type …

Background. Chronic kidney disease (CKD) has become a global public health problem with
a high prevalence and mortality. There is no sensitive and effective markers for chronic …

INTRODUCTION: Elevated levels of soluble urokinase-type plasminogen activator receptor
(suPAR) and other fibrinolytic parameters related to the urokinase-type plasminogen …

Introduction The soluble receptor of urokinase plasminogen activator (suPAR) is an innate
immunity/inflammation biomarker predicting cardiovascular (CV) and non-CV events in …

Soluble urokinase-type plasminogen activator receptor (suPAR) accumulates in patients
with chronic kidney disease (CKD). In various non-CKD populations, suPAR has been …

To the Editor: We read with interest the recent article by Wada et al. 1 on the role of soluble
urokinase plasminogen activator receptor (suPAR) levels in Japanese patients with focal …

It has been suggested that soluble urokinase receptor (suPAR) is a causative circulating
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …